Telix Pharmaceuticals agreed to acquire a German radioisotope maker in a scrip deal, and its shares fell sharply on implied dilution.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results